News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Kanesa-thasan Niranjan
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2023 |
5
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 5 on Icosavax, Inc. |
11/14/2022 |
4
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Granted 82,580 options to buy
@ $2.47, valued at
$204k
|
|
08/02/2022 |
4
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Sold 701 shares
@ $7.1076, valued at
$5k
Sold 2,001 shares
@ $6.6374, valued at
$13.3k
Sold 543 shares
@ $6.7038, valued at
$3.6k
|
|
02/14/2022 |
4
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Granted 19,485 shares
@ $0 Granted 81,950 options
@ $17.55, valued at
$1.4M
|
|
02/04/2022 |
4
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 4 on Icosavax, Inc.
Txns:
| Exercised 13,805 options to buy
@ $0.84, valued at
$11.6k
Exercised 38,947 options to buy
@ $1.04, valued at
$40.5k
|
|
08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/28/2021 |
3
| Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 3 on Icosavax, Inc. |
|
|